Offer - Urjas Oil for just ₹ 1
Cadrubin 50 mg Injection is a commercial drug that is prescribed in the form of Injection. Breast Cancer are some of its major therapeutic uses.
The optimal dosage of Cadrubin 50 mg Injection is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Cadrubin 50 mg Injection as well, which are listed below. Usually, these side effects of Cadrubin 50 mg Injection go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Cadrubin 50 mg Injection is Severe for pregnant women and Severe for women who are breastfeeding. Further, the section on Cadrubin 50 mg Injection related warnings talks about Cadrubin 50 mg Injection's effects on the liver, heart and kidney.
Some other conditions that can be affected by Cadrubin 50 mg Injection are listed in the contraindications section below.
Drug reaction of Cadrubin 50 mg Injection with other medicines has been reported. A complete list of these interactions is given below.
You should also be aware that Cadrubin 50 mg Injection is not safe while driving, and is not addiction.
Cadrubin 50 mg Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult(Female) |
|
| Geriatric |
|
Is the use of Cadrubin 50 mg Injection safe for pregnant women?
Cadrubin should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Cadrubin 50 mg Injection safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Cadrubin. So it is adviced to consult the doctor before using it.
What is the effect of Cadrubin 50 mg Injection on the Kidneys?
There may be some adverse effects on kidney after taking Cadrubin. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Cadrubin 50 mg Injection on the Liver?
There may be an adverse effect on the liver after taking Cadrubin. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Cadrubin 50 mg Injection on the Heart?
The heart can be affected by Cadrubin. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Cadrubin 50 mg Injection unless your doctor advises you to do so -
Is this Cadrubin 50 mg Injection habit forming or addictive?
No, there is no any evidence that Cadrubin 50 mg Injection is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Cadrubin 50 mg Injection. So it is best to avoid driving.
Is it safe?
Cadrubin 50 mg Injection should be used only after doctor's advice.
Is it able to treat mental disorders?
Cadrubin 50 mg Injection is unable to treat or cure mental disorders.
Interaction between Food and Cadrubin 50 mg Injection
It is safe to take Cadrubin 50 mg Injection with food.
Interaction between Alcohol and Cadrubin 50 mg Injection
Consuming Cadrubin 50 mg Injection with alcohol can have many serious effects on your body.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ellence® (epirubicin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 867
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 505-508
